![]() |
NEWS RELEASE
|
|
Three Months Ended
December 31,
|
Nine Months Ended
December 31,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net sales
|
$
|
122,568,000
|
$
|
125,574,000
|
$
|
372,654,000
|
$
|
385,096,000
|
||||||||
|
Cost of goods sold
|
98,327,000
|
97,913,000
|
295,300,000
|
303,279,000
|
||||||||||||
|
Gross profit
|
24,241,000
|
27,661,000
|
77,354,000
|
81,817,000
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
General and administrative
|
14,005,000
|
14,390,000
|
38,210,000
|
39,410,000
|
||||||||||||
|
Sales and marketing
|
4,698,000
|
5,623,000
|
13,224,000
|
15,990,000
|
||||||||||||
|
Research and development
|
2,100,000
|
2,174,000
|
6,014,000
|
6,694,000
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
(12,455,000
|
)
|
(3,772,000
|
)
|
(21,257,000
|
)
|
(2,507,000
|
)
|
||||||||
|
Total operating expenses
|
8,348,000
|
18,415,000
|
36,191,000
|
59,587,000
|
||||||||||||
|
Operating income
|
15,893,000
|
9,246,000
|
41,163,000
|
22,230,000
|
||||||||||||
|
Interest expense, net
|
4,051,000
|
6,879,000
|
12,074,000
|
19,575,000
|
||||||||||||
|
Income before income tax expense
|
11,842,000
|
2,367,000
|
29,089,000
|
2,655,000
|
||||||||||||
|
Income tax expense
|
3,373,000
|
1,502,000
|
8,448,000
|
1,752,000
|
||||||||||||
|
Net income
|
$
|
8,469,000
|
$
|
865,000
|
$
|
20,641,000
|
$
|
903,000
|
||||||||
|
Basic net income per share
|
$
|
0.44
|
$
|
0.05
|
$
|
1.09
|
$
|
0.05
|
||||||||
|
Diluted net income per share
|
$
|
0.44
|
$
|
0.04
|
$
|
1.07
|
$
|
0.05
|
||||||||
|
Weighted average number of shares outstanding:
|
||||||||||||||||
|
Basic
|
19,053,232
|
18,961,517
|
19,016,302
|
18,895,893
|
||||||||||||
|
Diluted
|
19,436,793
|
19,305,805
|
19,333,758
|
19,263,114
|
||||||||||||
|
December 31, 2020
|
March 31, 2020
|
|||||||
|
ASSETS
|
(Unaudited)
|
|||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
12,800,000
|
$
|
49,616,000
|
||||
|
Short-term investments
|
1,508,000
|
850,000
|
||||||
|
Accounts receivable — net
|
45,271,000
|
91,748,000
|
||||||
|
Inventory
|
296,281,000
|
234,680,000
|
||||||
|
Contract assets
|
25,382,000
|
20,332,000
|
||||||
|
Prepaid expenses and other current assets
|
13,866,000
|
11,890,000
|
||||||
|
Total current assets
|
395,108,000
|
409,116,000
|
||||||
|
Plant and equipment — net
|
54,464,000
|
44,957,000
|
||||||
|
Operating lease assets
|
74,685,000
|
53,029,000
|
||||||
|
Long-term deferred income taxes
|
16,603,000
|
18,950,000
|
||||||
|
Long-term contract assets
|
248,544,000
|
239,540,000
|
||||||
|
Goodwill and intangible assets — net
|
8,876,000
|
9,598,000
|
||||||
|
Other assets
|
956,000
|
1,839,000
|
||||||
|
TOTAL ASSETS
|
$
|
799,236,000
|
$
|
777,029,000
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued liabilities
|
$
|
146,073,000
|
$
|
95,083,000
|
||||
|
Customer finished goods returns accrual
|
34,267,000
|
25,326,000
|
||||||
|
Contract liabilities
|
44,778,000
|
27,911,000
|
||||||
|
Revolving loan
|
59,000,000
|
152,000,000
|
||||||
|
Other current liabilities
|
4,798,000
|
9,390,000
|
||||||
|
Operating lease liabilities
|
6,232,000
|
5,104,000
|
||||||
|
Current portion of term loan
|
3,678,000
|
3,678,000
|
||||||
|
Total current liabilities
|
298,826,000
|
318,492,000
|
||||||
|
Term loan, less current portion
|
17,705,000
|
20,462,000
|
||||||
|
Long-term contract liabilities
|
104,583,000
|
92,101,000
|
||||||
|
Long-term deferred income taxes
|
73,000
|
79,000
|
||||||
|
Long-term operating lease liabilities
|
71,569,000
|
61,425,000
|
||||||
|
Other liabilities
|
6,796,000
|
8,950,000
|
||||||
|
Total liabilities
|
499,552,000
|
501,509,000
|
||||||
|
Commitments and contingencies
|
||||||||
|
Shareholders’ equity:
|
||||||||
|
Preferred stock; par value $.01 per share, 5,000,000 shares authorized; none issued
|
-
|
-
|
||||||
|
Series A junior participating preferred stock; par value $.01 per share,
20,000 shares authorized; none issued
|
-
|
-
|
||||||
|
Common stock; par value $.01 per share, 50,000,000 shares authorized;
19,056,292 and 18,969,380 shares issued and outstanding at December 31, 2020 and
March 31, 2020, respectively
|
191,000
|
190,000
|
||||||
|
Additional paid-in capital
|
222,193,000
|
218,581,000
|
||||||
|
Retained earnings
|
84,758,000
|
64,117,000
|
||||||
|
Accumulated other comprehensive loss
|
(7,458,000
|
)
|
(7,368,000
|
)
|
||||
|
Total shareholders’ equity
|
299,684,000
|
275,520,000
|
||||||
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$
|
799,236,000
|
$
|
777,029,000
|
||||
| Items Impacting Net Income for the Three Months Ended December 31, 2020 and 2019 | Exhibit 1 |
|
Three Months Ended December 31,
|
||||||||||||||||
|
2020
|
2019
|
|||||||||||||||
| $ |
Per Share
|
$ |
Per Share
|
|||||||||||||
|
GAAP net income
|
$
|
8,469,000
|
$
|
0.44
|
$
|
865,000
|
$
|
0.04
|
||||||||
|
Items impacting net income
|
||||||||||||||||
|
Customer allowances related to new business
|
-
|
-
|
777,000
|
0.04
|
||||||||||||
|
Core buy-back premium amortization impacting net sales
|
1,528,000
|
0.08
|
1,326,000
|
0.07
|
||||||||||||
|
Impact of tariffs
|
(688,000
|
)
|
(0.04
|
)
|
-
|
-
|
||||||||||
|
New product line start-up costs and transition expenses (a)
|
4,550,000
|
0.23
|
2,815,000
|
0.15
|
||||||||||||
|
Revaluation - cores on customers’ shelves
|
1,304,000
|
0.07
|
2,395,000
|
0.12
|
||||||||||||
|
COVID-related expenses (b)
|
1,610,000
|
0.08
|
-
|
-
|
||||||||||||
|
Earn-out accruals and severance
|
44,000
|
0.00
|
310,000
|
0.02
|
||||||||||||
|
Share-based compensation expenses
|
1,498,000
|
0.08
|
1,071,000
|
0.06
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
(12,455,000
|
)
|
(0.64
|
)
|
(3,772,000
|
)
|
(0.20
|
)
|
||||||||
|
Tax effect (c)
|
652,000
|
0.03
|
(1,231,000
|
)
|
(0.06
|
)
|
||||||||||
| Items Impacting Net Income for the Nine Months Ended December 31, 2020 and 2019 |
Exhibit 2 |
|
Nine Months Ended December 31,
|
||||||||||||||||
|
2020
|
2019
|
|||||||||||||||
|
$
|
Per Share
|
$
|
Per Share
|
|||||||||||||
|
GAAP net income
|
$
|
20,641,000
|
$
|
1.07
|
$
|
903,000
|
$
|
0.05
|
||||||||
|
Items impacting net income
|
||||||||||||||||
|
Customer allowances, return accruals and changeover costs (a) related to new business, net of costs
|
307,000
|
0.02
|
1,231,000
|
0.06
|
||||||||||||
|
Core buy-back premium amortization impacting net sales
|
4,269,000
|
0.22
|
3,543,000
|
0.18
|
||||||||||||
|
Impact of tariffs
|
(3,535,000
|
)
|
(0.18
|
)
|
1,067,000
|
0.06
|
||||||||||
|
Cost in connection with a cancelled contract
|
-
|
133,000
|
0.01
|
|||||||||||||
|
New product line start-up costs and transition expenses (b)
|
12,564,000
|
0.65
|
7,465,000
|
0.39
|
||||||||||||
|
Revaluation - cores on customers’ shelves, and gain due to realignment of inventory at two customer distribution
centers
|
(811,000
|
)
|
(0.04
|
)
|
9,867,000
|
0.51
|
||||||||||
|
COVID-related expenses (c)
|
5,953,000
|
0.31
|
-
|
-
|
||||||||||||
|
Acquisition costs, earn-out accruals, severance and restatement-related fees
|
19,000
|
0.00
|
292,000
|
0.02
|
||||||||||||
|
Share-based compensation expenses
|
3,759,000
|
0.19
|
3,112,000
|
0.16
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
(21,257,000
|
)
|
(1.10
|
)
|
(2,507,000
|
)
|
(0.13
|
)
|
||||||||
|
Tax effect (d)
|
(317,000
|
)
|
(0.02
|
)
|
(6,051,000
|
)
|
(0.31
|
)
|
||||||||
| Items Impacting Gross Profit for the Three Months Ended December 31, 2020 and 2019 | Exhibit 3 |
|
Three Months Ended December 31,
|
||||||||||||||||
|
2020
|
2019
|
|||||||||||||||
|
$
|
Gross
Margin
|
$
|
Gross
Margin
|
|||||||||||||
|
GAAP gross profit
|
$
|
24,241,000
|
19.8
|
%
|
$
|
27,661,000
|
22.0
|
%
|
||||||||
|
Items impacting gross profit
|
||||||||||||||||
|
Customer allowances related to new business
|
-
|
-
|
777,000
|
0.6
|
%
|
|||||||||||
|
Core buy-back premium amortization impacting net sales
|
1,528,000
|
1.2
|
%
|
1,326,000
|
1.1
|
%
|
||||||||||
|
Impact of tariffs
|
(688,000
|
)
|
-0.6
|
%
|
-
|
-
|
||||||||||
|
New product line start-up costs and transition expenses
|
4,217,000
|
3.4
|
%
|
2,148,000
|
1.7
|
%
|
||||||||||
|
Revaluation - cores on customers’ shelves
|
1,304,000
|
1.1
|
%
|
2,395,000
|
1.9
|
%
|
||||||||||
|
COVID-related expenses
|
1,052,000
|
0.9
|
%
|
-
|
-
|
|||||||||||
| Items Impacting Gross Profit for the Nine Months Ended December 31, 2020 and 2019 | Exhibit 4 |
|
Nine Months Ended December 31,
|
||||||||||||||||
|
2020
|
2019
|
|||||||||||||||
|
$
|
Gross
Margin
|
$
|
Gross
Margin
|
|||||||||||||
|
GAAP gross profit
|
$
|
77,354,000
|
20.8
|
%
|
$
|
81,817,000
|
21.2
|
%
|
||||||||
|
Items impacting gross profit
|
||||||||||||||||
|
Customer allowances and return accruals related to new business, net of costs
|
307,000
|
0.1
|
%
|
1,119,000
|
0.3
|
%
|
||||||||||
|
Core buy-back premium amortization impacting net sales
|
4,269,000
|
1.1
|
%
|
3,543,000
|
0.9
|
%
|
||||||||||
|
Impact of tariffs
|
(3,535,000
|
)
|
-0.9
|
%
|
1,067,000
|
0.3
|
%
|
|||||||||
|
Cost in connection with a cancelled contract
|
-
|
-
|
133,000
|
0.0
|
%
|
|||||||||||
|
New product line start-up costs and transition expenses
|
11,572,000
|
3.1
|
%
|
5,829,000
|
1.5
|
%
|
||||||||||
|
Revaluation - cores on customers’ shelves, and gain due to realignment of
inventory at two customer distribution centers (a)
|
(811,000
|
)
|
0.5
|
%
|
9,867,000
|
2.6
|
%
|
|||||||||
|
COVID-related expenses
|
4,425,000
|
1.2
|
%
|
-
|
-
|
|||||||||||
| Items Impacting EBITDA for the Three and Nine Months Ended December 31, 2020 and 2019 | Exhibit 5 |
|
Three Months Ended December 31,
|
Nine Months Ended December 31,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
GAAP net income
|
$
|
8,469,000
|
$
|
865,000
|
$
|
20,641,000
|
$
|
903,000
|
||||||||
|
Interest expense, net
|
4,051,000
|
6,879,000
|
12,074,000
|
19,575,000
|
||||||||||||
|
Income tax expense
|
3,373,000
|
1,502,000
|
8,448,000
|
1,752,000
|
||||||||||||
|
Depreciation and amortization
|
2,857,000
|
2,400,000
|
8,090,000
|
7,019,000
|
||||||||||||
|
EBITDA
|
$
|
18,750,000
|
$
|
11,646,000
|
$
|
49,253,000
|
$
|
29,249,000
|
||||||||
|
Items impacting EBITDA
|
||||||||||||||||
|
Customer allowances, return accruals and changeover costs related to new business, net of costs
|
-
|
777,000
|
307,000
|
1,231,000
|
||||||||||||
|
Core buy-back premium amortization impacting net sales
|
1,528,000
|
1,326,000
|
4,269,000
|
3,543,000
|
||||||||||||
|
Impact of tariffs
|
(688,000
|
)
|
-
|
(3,535,000
|
)
|
1,067,000
|
||||||||||
|
Cost in connection with a cancelled contract
|
-
|
-
|
-
|
133,000
|
||||||||||||
|
New product line start-up costs and transition expenses (a)
|
4,421,000
|
2,733,000
|
12,235,000
|
7,246,000
|
||||||||||||
|
Revaluation - cores on customers’ shelves, and gain due to realignment of inventory at two customer distribution
centers
|
1,304,000
|
2,395,000
|
(811,000
|
)
|
9,867,000
|
|||||||||||
|
COVID-related expenses
|
1,610,000
|
-
|
5,953,000
|
-
|
||||||||||||
|
Acquisition costs, earn-out accruals, severance and restatement-related fees
|
44,000
|
310,000
|
19,000
|
292,000
|
||||||||||||
|
Share-based compensation expenses
|
1,498,000
|
1,071,000
|
3,759,000
|
3,112,000
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
(12,455,000
|
)
|
(3,772,000
|
)
|
(21,257,000
|
)
|
(2,507,000
|
)
|
||||||||